Stage IV renal cell carcinoma achieves pathologic complete response after two ipilimumab plus nivolumab courses despite severe immune-related adverse events: a case report
Article in Journal of Pharmaceutical Health Care and Sciences (May 2024)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Article in Journal of Pharmaceutical Health Care and Sciences (May 2024)
Article in BMC Medical Imaging (November 2023)
Article in Current Issues in Molecular Biology (July 2023)